Table 4.
Treatment |
P value | Contrasts |
SE | |||||||
---|---|---|---|---|---|---|---|---|---|---|
Variables | Unchallenged control | Challenged control | 0.125% DTB | 0.25% DTB | 0.5% DTB | L1 | Q | |||
FITC-d | −0.008b | 0.241a | 0.222a | 0.269a | 0.282a | <0.001 | 0.423 | 0.915 | 0.0424 | |
Gene expression | ||||||||||
20 d (6 dpi) | CLDN-1 | 1.000 | 2.775 | 2.788 | 1.369 | 2.074 | 0.117 | 0.310 | 0.336 | 0.5768 |
Occludin | 1.000a | 0.904b | 0.807c | 0.882bc | 0.829bc | 0.014 | 0.422 | 0.720 | 0.0399 | |
Muc-2 | 1.000a | 0.669b | 0.550c | 0.588bc | 0.610bc | <0.001 | 0.611 | 0.112 | 0.0398 | |
26 d (12 dpi) | CLDN-1 | 1.000 | 1.298 | 1.228 | 1.010 | 0.869 | 0.101 | 0.017 | 0.791 | 0.1287 |
Occludin | 1.000 | 0.991 | 0.989 | 0.960 | 0.886 | 0.486 | 0.109 | 0.658 | 0.0525 | |
Muc-2 | 1.000a | 0.884b | 0.897ab | 0.752c | 0.724c | 0.001 | 0.011 | 0.751 | 0.0512 | |
Antioxidant system | ||||||||||
20 d (6 dpi) | SOD | 5.570 | 5.748 | 5.502 | 5.595 | 5.495 | 0.742 | 0.373 | 0.635 | 0.1536 |
GPx | 0.027c | 0.036b | 0.042a | 0.041ab | 0.037b | <0.001 | 0.715 | 0.052 | 0.0022 | |
GSH | 4.271a | 3.241b | 2.831b | 2.836b | 2.828b | <0.001 | 0.401 | 0.412 | 0.2723 | |
GSSG | 0.290 | 0.514 | 0.521 | 0.343 | 0.277 | 0.234 | 0.060 | 0.895 | 0.1236 | |
GSH:GSSG | 18.006 | 9.091 | 10.959 | 19.423 | 15.820 | 0.689 | 0.407 | 0.460 | 7.7108 | |
26 d (12 dpi) | GSH | 3.784ab | 3.294bc | 3.966a | 3.145c | 2.729c | 0.005 | 0.021 | 0.177 | 0.2443 |
GSSG | 0.312 | 0.212 | 0.241 | 0.293 | 0.356 | 0.783 | 0.182 | 0.959 | 0.1184 | |
GSH:GSSG | 29.662 | 40.963 | 65.709 | 17.668 | 7.723 | 0.110 | 0.068 | 0.699 | 23.3339 |
Means followed by superscript letters are different by Tukey's test (P < 0.05; P < 0.10) within the row.
L, linear effect; Q, quadratic effect.
SE = pooled standard error.